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REVIEW CURRENTOPINION Physiology of breathlessness associated with
pleural effusions Copyright 
www.co-pulmonarymedicine.ca,b,c d,e,f g,hRajesh Thomas , Susan Jenkins , Peter R. Eastwood
Y.C. Gary Leea,b,c, and Bhajan Singhg,hPurpose of review
Pleural effusions have a major impact on the cardiorespiratory system. This article reviews the
pathophysiological effects of pleural effusions and pleural drainage, their relationship with breathlessness,
and highlights key knowledge gaps.
Recent findings
The basis for breathlessness in pleural effusions and relief following thoracentesis is not well understood.
Many existing studies on the pathophysiology of breathlessness in pleural effusions are limited by small
sample sizes, heterogeneous design and a lack of direct measurements of respiratory muscle function. Gas
exchange worsens with pleural effusions and improves after thoracentesis. Improvements in ventilatory
capacity and lung volumes following pleural drainage are small, and correlate poorly with the volume of
fluid drained and the severity of breathlessness. Rather than lung compression, expansion of the chest wall,
including displacement of the diaphragm, appears to be the principle mechanism by which the effusion is
accommodated. Deflation of the thoracic cage and restoration of diaphragmatic function after thoracentesis
may improve diaphragm effectiveness and efficiency, and this may be an important mechanism by which
breathlessness improves. Effusions do not usually lead to major hemodynamic changes, but large effusions
may cause cardiac tamponade and ventricular diastolic collapse. Patients with effusions can have impaired
exercise capacity and poor sleep quality and efficiency.
Summary
Pleural effusions are associated with abnormalities in gas exchange, respiratory mechanics, respiratory
muscle function and hemodynamics, but the association between these abnormalities and breathlessness
remains unclear. Prospective studies should aim to identify the key mechanisms of effusion-related
breathlessness and predictors of improvement following pleural drainage.
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annually in the United States alone [1]. Pleural
effusions have more than 60 different causes, and
vary in size and risk (and rates) of recurrence. Con-
gestive heart failure (CHF), malignancy, pulmonary
infection and embolism account for over 90% of
pleural effusions [2].
Pleural effusions can impact profoundly on the
cardiorespiratory system. Breathlessness, the com-
monest presentation, is often debilitating and signifi-
cantly impairs quality of life. Relief of breathlessness
often necessitates therapeutic pleural interventions
with associated discomfort, risks of infection, bleed-
ing, pneumothorax and even death. Management of
pleural effusions represents a significant healthcare
burden worldwide.
To date, research on, and hence our understand-
ing of, the effects of pleural effusions on respiratory© 2015 Wolters Kluwer Health, Inc. All rights reserved.
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KEY POINTS
 Pleural effusions can affect the cardiorespiratory system,
exercise capacity and sleep.
 Gas exchange worsens with pleural effusions and
improves following thoracentesis.
 Improvements in ventilatory capacity and lung volumes
following pleural drainage are small, and correlate
poorly with the volume of fluid drained and the severity
of breathlessness.
 Chest wall expansion and displacement of the
diaphragm are the principle mechanisms by which the
effusion is accommodated; deflation of the thoracic
cage and restoration of diaphragmatic function after
thoracentesis may be important mechanisms by which
breathlessness improves.
 Effusions do not usually cause major hemodynamic
changes, but large effusions may cause cardiac
tamponade and ventricular diastolic collapse.
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conventional belief that pleural effusions cause
breathlessness through compression of the lung is
overly simplistic. The severity of breathlessness
often correlates poorly with the size of the effusion
[3
&
,4,5] Conversely, symptom reduction from fluid
drainage varies significantly between patients, and
no reliable predictors exist to identify those who will
benefit. Most previous studies have involved small
cohorts and examined specific etiological factors in
isolation; few have compared physiological changes
with symptom benefits in patients.
This article reviews published literature on the
pathophysiological effects of pleural effusions
(and their therapeutic evacuation). Key knowledge
gaps are highlighted which may guide future
research.LITERATURE SEARCH
Medline, Excerpta Medica dataBASE (EMBASE) and
the Cochrane Database of Systematic Reviews were
interrogated using the following search terms, such as
‘pleural effusion’ and ‘oxygenation’ (gas exchange,
hypoxemia and oxygen desaturation), ‘pulmonary
function test’ (lung functiontest, respiratory function
test and spirometry), ‘pleural pressure’ (Ppl, pleural
elastance), ‘exercise’ [6-min walk test (6MWT), car-
diopulmonary exercise test], ‘sleep’, ‘cardiac’ (hemo-
dynamic effects, hypotension) and ‘dyspnea’
(breathlessness). References and their citation lists
were scrutinized. Studies pertaining to the effects of
pleural effusion on pulmonary physiology and
breathlessness were included. Copyright © 2015 Wolters Kluwe
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PLEURAL EFFUSION
Most studies on the pathophysiologic effects of
effusions have included small numbers of patients
who are heterogeneous in their underlying pleural
and systemic diseases, and many have been con-
ducted in different settings (e.g. ventilated vs. spon-
taneous breathing patients). Therefore, care must be
executed in interpreting their findings.Gas exchange
Pleural effusions can worsen gas exchange. Instilla-
tion of physiological saline into both pleural spaces
of mechanically ventilated pigs has been shown to
induce early and dose-related hypoxemia [6]. Intra-
pulmonary shunt was shown to underlie the hypo-
xemia when Agusti et al. [7] examined patients
(n¼9) with recent-onset pleural effusions using
the multiple inert gas elimination technique.
Thoracentesis appears to improve gas exchange.
A meta-analysis of 19 studies (1124 patients) [8
&
] on
thoracentesis in mechanically ventilated patients
showed an average improvement in PaO2:FiO2 of
18%. Improvements in gas exchange are more con-
sistently found at 24 h [5,9], rather than immedi-
ately [7,10–12] after thoracentesis. Hypoxemia has
been shown to worsen up to 2 h after thoracentesis
[13]. These observations have been attributed to re-
expansion pulmonary edema or delayed pulmonary
re-expansion.
Several factors may influence the improvement
in gas exchange with thoracentesis. In mechanically
ventilated patients, improvements in PaO2:FiO2
have been associated with the volume drained
[14] and the increase in end-expiratory lung volume
[15
&
]; those with lower PaO2:FiO2 ratios appeared to
have greater benefit. Patients with acute respiratory
distress syndrome appeared to have less improve-
ment in gas exchange [15
&
,16]. In mechanically
ventilated patients with CHF effusions, the
improvement in PaO2:FiO2 after thoracentesis cor-
related inversely with pleural elastance [17].
Improvements in oxygenation are greater in
patients with diaphragm paradox [18]. No evidence
links abnormal gas exchange caused by pleural effu-
sions (and their improvements postthoracentesis) to
the symptom of breathlessness.Pulmonary function and respiratory
mechanics
Studies of pleural effusion and pulmonary function
are often heterogeneous in their designs and phys-
iological indices measured. Nonetheless, most stud-
ies agree that increases in lung volumes are smallr Health, Inc. All rights reserved.
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FEV1 3.87 1.07 27 1.67 43 600
FVC 5.14 1.35 26 2.01 39 660
TLC 7.65 2.89 37 3.48 45 590
RV 2.50 1.56 62 1.37 54 190
The improvements in vital capacity and total lung capacity (TLC) were less than half the volume of pleural fluid removed. FEV1, forced expiratory volume in 1 s;
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FIGURE 1. Expiratory flow-volume loops before (red) and
4 h after (blue) thoracocentesis of 1.3 l in a 62-year-old man
with large malignant right pleural effusion. Thoracocentesis
resulted in increases in vital capacity, total lung capacity
and peak expiratory flow, but they remain severely reduced
due to underlying pulmonary and pleural disease. FVC,
forced vital capacity.
Diseases of the pleuraand correlate poorly [19] (or not at all [10]) with the
volume of pleural fluid drained [4,5,10,19,20] irre-
spective of whether the effusion is a transudate or
exudates [21].
Animal and human studies suggest that expan-
sion in the thoracic cage is the principle mechanism
by which extra volume is generated to accommo-
date the effusion, and helps preserve lung volumes.
In anesthetized dogs, infusion of saline intrapleur-
ally increased thoracic cage volume by two-thirds of
the total volume instilled but only reduced the
functional residual capacity (FRC) by one-third of
the total volume instilled [22,23]. The increase in
thoracic cage volume was achieved mainly through
downward displacement of the diaphragm [23,24].
In rats, bilateral pleural effusions also increased both
the anteroposterior and lateral rib cage diameters
[24]. Acute pleural effusions increase respiratory
system elastance by increasing lung elastance
[24,25], likely via lung distortion and decreases in
FRC. The effect of pleural effusions on lung resist-
ance is unclear. [24,25] Pleural effusions do not
appear to alter chest wall elastance or resistance
[24,25].
Our knowledge on the effect of effusion on lung
volume in humans comes mainly from changes
measured prethoracentesis and postthoracentesis.
Although thoracentesis can improve the forcedexpir-
atory volume in 1 s (FEV1), vital capacity and lung
volumes [3
&
,4,5,10,18] the magnitudes of increase are
highly variable and often do not correlate with the
volume of fluid drained [3
&
,10]. (Table 1 and Fig. 1) In
26 patients who had thoracentesis (1.740.90 l), the
vital capacity and total lung capacity increased by
0.410.39 and 0.700.20 l, respectively, after 24 h.
The improvement correlated best with the Ppl after
0.80 l of fluid had been withdrawn [19]. The effect of
thoracentesis on FEV1 and vital capacity appears to be
greater in patients with paradoxical movement of
their hemidiaphragm [18]. Another small study
(n¼9) [4] also found similar modest improvements
of vital capacity (median 0.30 l) and total lung
capacity (0.64 l) compared with the volume of fluid Copyright © 2015 Wolters Kluwer 
340 www.co-pulmonarymedicine.comevacuated (1.820.60 l). These human data are con-
sistent with findings in animal studies that effusions
are accommodated mainly through expansion of the
thoracic cage rather than lung compression.
A study of 129 acute respiratory distress syn-
drome patients [16] found that small (median
287 ml) pleural effusions were associated with
greater increases in thoracic cage volume than
reduction in lung volume and had no significant
effects on respiratory mechanics. Two studies of
mechanically ventilated patients [15
&
,26] with acute
respiratory failure showed that thoracentesis
improved compliance and respiratory resistance
within 24 h. However, the improvement in respir-
atory compliance, respiratory resistance, elastic lung
recoil and intrinsic positive end-expiratory pressure
may not be apparent within the initial 2 h after
thoracentesis [4,11,15
&
]. Thoracentesis does not
appear to significantly alter the diffusing capacity
of lung for carbon monoxide [7,21] specific airwayHealth, Inc. All rights reserved.
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volume ratio [9,21].
Taken together these data suggest that sympto-
matic benefits of pleural drainage may result from
deflation of the thoracic cage and associated
improvements in inspiratory muscle function.Pleural pressure
In health, Ppl at FRC is determined by the balance of
elastic recoil pressures of the lung and chest wall, and
is usually subatmospheric (3 to 5 cmH2O). In
mechanically ventilated pigs with an artificially cre-
ated pleural effusion, the Ppl progressively increases
toward the most dependent part of the effusion [6].
However, Ppl is highly variable in patients with pleu-
ral effusions and may be either increased or reduced
[27,28]. In a study of 52 patients with pleural effu-
sions, Light et al. [27] found that Ppl ranged from21
to þ8 cmH2O. This difference may be explained by
concurrent pulmonary pathologies in patients. Ppl
can be reduced (<5 cmH2O) particularly in patients
with a trapped lung [28].
Thoracentesis lowers Ppl [7,19,27,28] and the
ratio of the fall in Ppl to the volume drained defines
the pleural space elastance. During thoracentesis,
Ppl usually falls most rapidly in the initial and final
phases of drainage. The magnitude of the fall in Ppl
with thoracentesis and pleural space elastance is
highly variable [27]. Differences in Ppl prior to
thoracentesis and pleural space elastance have been
proposed to have diagnostic and prognostic values,
and three patterns have been described. First, in
patients with pleural effusion and normal lung elas-
tic recoil, airway patency and visceral pleura, Ppl is
elevated and pleural space elastance is low. Second, a
reduced Ppl with high pleural space elastance
(>25 cmH2O/l) [27,28] is often seen in patients
whose lung is trapped (e.g. by malignancy), and is
associated with pleurodesis failure [29]. A third pat-
tern is seen in the presence of nonexpandable lungs
due to airway obstruction, increased lung elastic
recoil or pleural inflammation in which Ppl is often
increased at baseline and elastance is also raised.
A high baseline Ppl (and smaller reductions in
Ppl postthoracentesis) was associated with greater
increase in vital capacity in one study (n¼26) [19]
but with less increase in end-expiratory lung volume
in another (n¼20 ventilated patients) [15&]. Patients
with low pleural space elastance had the greatest
improvement in gas exchange in a study of 26
ventilated patients with CHF. Light et al. [27] pro-
posed that Ppl below 20 cmH2O postthoracentesis
was associated with a higher likelihood of re-expan-
sion pulmonary edema but this has not been con-
firmed by other studies [30]. Copyright © 2015 Wolters Kluwe
1070-5287 Copyright  2015 Wolters Kluwer Health, Inc. All rights reseWhether Ppl and pleural space elastance
changes correlate with changes in breathlessness
remains unknown.Cardiovascular function
Small or moderate effusions, and their drainage,
generally do not cause major hemodynamic
changes. Even in mechanically ventilated patients
fluid evacuation does not significantly alter blood
pressure, cardiac output (CO) or catecholamine dose
requirements [15
&
]. Detailed description of the
effects of pleural effusion on cardiovascular func-
tion is beyond the scope of this article.
Large effusions do not usually reduce CO at rest
but can limit its rise during exercise [31]. When
saline up to 40 ml/kg was infused into both hemi-
thoraces of dogs, pulmonary artery occlusion pres-
sure and central venous pressure increased in
proportion to the pleural fluid added. The CO did
not change until a larger volume (40–80 ml/kg) was
instilled when the CO dropped significantly and
caused death in many animals [6]. The hemody-
namic changes of large bilateral effusions in dogs
mimic those of pericardial tamponade: elevated
intrapericardial pressure, impaired cardiac filling
and stroke volume and right ventricular diastolic
collapse [32]. Ventricular diastolic collapse can also
be seen with large, unilateral effusions and resolves
quickly postthoracentesis [33].Exercise
Breathlessness in patients with pleural effusions is
most prominent during exertion. Only two studies
have examined the effect of pleural effusion and
thoracentesis on exercise capacity. Both studies
showed impairment of baseline exercise capacity
in patients with effusions and benefits from
thoracentesis.
One study (n¼25) employed the 6MWT [3&] and
found an average baseline distance of 43278 m
(73% predicted). The other (n¼15) used incremental
cardiopulmonary exercise test [34] which revealed a
mean maximum oxygen consumption per minute
(VO2max) of only 37% of the predicted values.
The 6MWT distance improved by 15% (63 m)
after thoracentesis (1.560.70 l). This improve-
ment correlated with increases in ventilatory
capacity, but neither correlated with the volume
of fluid removed. Breathlessness improved signifi-
cantly at rest (Borg scores from 2.7 to 1.5) and after
exercise (from 5.1 to 2.4), even though oxygenation
did not improve.
In the study using cardiopulmonary exercise test
[34], improvements in exercise tolerance, maximumr Health, Inc. All rights reserved.
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Diseases of the pleuraworkload and VO2max following therapeutic thora-
centesis (mean 1.6 l removed) were variable. Change
in VO2max postthoracentesis correlated with
changes in FEV1 (r¼0.58), forced vital capacity
(r¼0.61) and maximum O2 pulse (r¼0.78). Again,
no correlation with the amount of fluid removed
was found.FIGURE 2. Computed tomography scan (axial view) shows
expansion of the right thoracic cage (with increased
anteroposterior diameter and widened intercostal space) to
accommodate a large pleural effusion.Sleep
Only one published study has examined the effect of
pleural effusion on sleep [35
&
] and found poor sleep
quality and efficiency in patients (n¼19) with a
large pleural effusion at baseline as measured by
the Pittsburgh Sleep Quality Index and overnight
sleep studies.
Thoracentesis improved total sleep time, sleep
efficiency (from 76 to 81%) and rapid eye movement
sleep, and reduced stage 1 sleep and Borg score (from
2.3 to 0.8). No correlation existed between the vol-
ume of pleural fluid removed (mean 1.6 l) and the
improvement in sleep or dyspnea scores.FIGURE 3. Computed tomography scan (coronal view)
shows the right diaphragm that is pushed down by a
moderate pleural effusion to a level lower than the left
diaphragm. It shows the effect of the weight of fluid on the
diaphragm even when the patient is in the supine position.
This is likely to be worse when the patient is in an upright
position.THE DIAPHRAGM IN EFFUSION-RELATED
BREATHLESSNESS
Breathlessness from pleural effusions is likely multi-
factorial. The contribution of concurrent extrapleu-
ral diseases to breathlessness must be considered
when evaluating patients with a pleural effusion.
As discussed earlier, pleural effusions are accom-
modated by a greater expansion of the thoracic cage
(Fig. 2) than reduction in lung volume [16,22,23].
Greater compliance of the thoracic cage reduces the
impact of the effusion on lung mechanics and gas
exchange. A considerable proportion of the expan-
sion of the thoracic cage occurs in the vertical
dimension [23,24]. In erect humans, this would
result in distortion of the hemidiaphragm causing
a downward displacement of the dome of the dia-
phragm (Fig. 3), and reductions in muscle length
and area of apposition of the diaphragm with the rib
cage. Moderate or large effusions commonly cause
flattening (Figs 4 and 5) or even inversion of the
diaphragm (Fig. 6), and this is associated with severe
breathlessness [5]. These changes are likely to render
the diaphragm less effective and efficient. The short-
ened diaphragm has a reduced capacity to develop
tension, requires higher neural activation to develop
an equivalent tension [36] and is less effective at
translating tension to transdiaphragmatic pressure
[37]. The smaller area of apposition reduces the
capacity for increases in abdominal pressure during
inspiration to expand the rib cage. The finding of
paradoxical movement of the hemidiaphragm in
response to a unilateral pleural effusion [18] is Copyright © 2015 Wolters Kluwer 
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of the hemidiaphragm when loaded with a large
effusion. These effects of pleural effusions on the
diaphragm are likely to result in a reduced venti-
latory output relative to neural drive of the dia-
phragm (‘neuromechanical uncoupling’). There isHealth, Inc. All rights reserved.
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FIGURE 4. (a, b) Computed tomography scan (sagittal view) and ultrasound showing flattened right diaphragm caused by a
moderate pleural effusion.
Physiology of breathlessness with pleural effusions Thomas et al.considerable evidence that such neuromechanical
uncoupling generates afferent neural impulses from
mechanoreceptors throughout the respiratory sys-
tem (muscle, chest wall, airways and lung paren-
chyma) to the sensorimotor cortex and results in the
sensation of breathlessness [38,39].
Impairment of hemidiaphragm function caused
by a large pleural effusion, for reasons discussed
above, may also cause ‘pendulum breathing’ where
paradoxical movement of the diaphragm allows the
movement of air from the abnormal hemithorax to
the normal hemithorax during inspiration. This will
impair ventilatory efficiency further and may con-
tribute to breathlessness [40,41]. Breathlessness
from pendulum breathing is only relieved on lying






FIGURE 5. (a, b) The normal shape of the right diaphragm is res
1070-5287 Copyright  2015 Wolters Kluwer Health, Inc. All rights reseThoracentesis often results in an immediate and
dramatic improvement in breathlessness and exer-
cise tolerance that cannot be explained onthebasisof
improvements in ventilatory capacity, gas exchange
or mechanical properties of the lung. It is likely that
thoracentesis restores respiratory muscles, in particu-
lar the diaphragm, to a more normal length and
shape immediately (Figs 4–6). This immediate
improvement in neuromechanical coupling may
be the basis for a corresponding immediate improve-
ment in symptoms. This may explain why patients
with paradoxical diaphragmatic movements are sig-
nificantly more breathless than those without (Borg
scores 5.1 vs. 2.9, respectively), and are more likely to
improve in their breathlessness [18] and exercise





tored following therapeutic drainage of 1 l of pleural fluid.
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FIGURE 6. (a, b) CT scan (coronal and sagittal views) shows a large pleural effusion pushing down and inverting the left
diaphragm. (c, d) The left diaphragm reverts to its normal shape and position following complete evacuation of the effusion.
Diseases of the pleuraKNOWLEDGE GAP AND FUTURE
DIRECTIONS
Pleural effusion is common and therapeutic drain-
ages are performed worldwide everyday despite
there being limited understanding of the mechan-
ism of breathlessness and no accurate predictors to
guide patient selection.
Definitive studies to examine the cause of
breathlessness in pleural effusion are challenging
to perform. Prior attempts have been limited by
small and markedly heterogeneous patient cohorts
that include a wide range of pleural effusions of
different causes, size and the acuity of accumulation
in patients of varying severity of breathlessness/
hypoxemia and concurrent cardiorespiratory dis-
eases. Variations in study protocols and endpoints
also make comparisons difficult. For example, differ-
ent assessment times after drainage (ranging from
immediately to 48 h postdrainage) complicate result
interpretation. Differences in fluid volume removed
further confound the results. Copyright © 2015 Wolters Kluwer 
344 www.co-pulmonarymedicine.comDefining the optimal tool to assess breathless-
ness in pleural effusion must be a priority. Prospec-
tive studies to identify key factors governing
breathlessness with pleural effusions and to develop
predictors of improvement following pleural drain-
age are needed. Ideally a comprehensive approach
incorporating clinical, physiological and radiologi-
cal parameters in a large unbiased patient popu-
lation should be employed.
The ability to select and limit pleural interven-
tions to patients who are likely to have symptomatic
benefits from fluid drainage would represent a major
advance in pleural medicine.CONCLUSION
Pleural effusions have major effects on the cardio-
respiratory system and cause abnormalities in gas
exchange, respiratory mechanics and muscle function
and hemodynamics. The association between these
abnormalities and effusion-related breathlessness,Health, Inc. All rights reserved.
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Physiology of breathlessness with pleural effusions Thomas et al.and the response following thoracentesis, remains
uncertain. Future research should aim to identify the
keymechanismsdrivingbreathlessness inpatientswith
a pleural effusion and the important predictors of
improvement following pleural drainage.
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